Literature DB >> 24771395

How California Institute for Regenerative Medicine research programs support science and regulatory policy.

Geoffrey P Lomax1, Natalie D DeWitt2, Maria T Millan2, Ellen G Feigal2.   

Abstract

Keywords:  Clinical trials; Drug target; Genomics; Induced pluripotent stem cells

Mesh：

Year:  2014        PMID： 24771395      PMCID： PMC4039461          DOI： 10.5966/sctm.2014-0069

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN： 2157-6564            Impact factor:   6.940


× No keyword cloud information.
  3 in total

1.  The proceedings of the California Stem Cell Agency.

Authors:  Ellen G Feigal; Natalie D DeWitt
Journal:  Stem Cells Transl Med       Date:  2014-04-25       Impact factor: 6.940

2.  Application of artificial intelligence in glioma researches: A bibliometric analysis.

Authors:  Dewei Zhang; Weiyi Zhu; Jun Guo; Wei Chen; Xin Gu
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

Review 3.  Human in vitro models for understanding mechanisms of autism spectrum disorder.

Authors:  Aaron Gordon; Daniel H Geschwind
Journal:  Mol Autism       Date:  2020-04-16       Impact factor: 7.509
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.